Menarini Silicon Biosystems
Thomas Johnson is an accomplished executive in the field of quality assurance and regulatory affairs, currently serving as the Vice President at Menarini Silicon Biosystems since January 2023. Johnson has extensive experience, having previously held leadership positions at Akoya Biosciences, QSCS, Fresenius Medical Care, Haemonetics, Covidien, Amgen, Boston Scientific, PricewaterhouseCoopers, and Bradford Soap Works. Notable achievements include overseeing quality systems for global healthcare providers and ensuring regulatory compliance across multiple medical device and pharmaceutical sectors. Johnson holds an MBA in Business from Norwich University and a Bachelor’s degree in Biology from Quinnipiac University.
This person is not in any offices
Menarini Silicon Biosystems
1 followers
Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArray™ technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision. Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries. Read our Netiquette here: www.siliconbiosystems.com/netiquette